相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2020)
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer
Ismaheel O. Lawal et al.
CURRENT OPINION IN UROLOGY (2020)
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S. Hofman et al.
LANCET (2020)
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
Philipp Nuhn et al.
EUROPEAN UROLOGY (2019)
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P. Fendler et al.
JAMA ONCOLOGY (2019)
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer A critical review
Alessandro Sciarra et al.
MEDICINE (2019)
Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
Lucile Broncy et al.
CELLS (2019)
Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone an Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Jae-Seung Chung et al.
NEOPLASIA (2019)
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Klaus Pantel et al.
CLINICAL CHEMISTRY (2019)
Prostate Cancer Research at the Crossroads
Michael M. Shen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Detection of CTC Clusters and a Dedifferentiated RNA-Expression Survival Signature in Prostate Cancer
Molly Kozminsky et al.
ADVANCED SCIENCE (2019)
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature
Udit Singhal et al.
MOLECULAR CANCER RESEARCH (2018)
AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients
Takatsugu Okegawa et al.
PROSTATE (2018)
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients
Manish Kohli et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2018)
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer A Phase 2 Clinical Trial
Karen A. Autio et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
A disposable microfluidic device with a reusable magnetophoretic functional substrate for isolation of circulating tumor cells
Hyungseok Cho et al.
LAB ON A CHIP (2017)
68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
Cristian Udovicich et al.
PROSTATE INTERNATIONAL (2017)
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood
Cecilia Magnusson et al.
ANALYTICAL CHEMISTRY (2017)
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies
Yafeng Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A. Azad et al.
CLINICAL CANCER RESEARCH (2015)
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Acoustic separation of circulating tumor cells
Peng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Detecting predictive androgen receptor modifications in circulating prostate cancer cells
Oncotarget (2015)
Detection of Circulating Cytokeratin-19 mRNA-Positive Cells in the Blood and the Mitotic Index of the Primary Tumor Have Independent Prognostic Value in Early Breast Cancer
Konstantinos Tryfonidis et al.
CLINICAL BREAST CANCER (2014)
Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations
Gregory J. Tsongalis et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Circulating tumour cells-monitoring treatment response in prostate cancer
David T. Miyamoto et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells
Angel E. Dago et al.
PLOS ONE (2014)
Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations
Ephrem L. H. Chin et al.
BMC GENETICS (2013)
Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
Emre Ozkumur et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Microfluidic, Label-Free Enrichment of Prostate Cancer Cells in Blood Based on Acoustophoresis
Per Augustsson et al.
ANALYTICAL CHEMISTRY (2012)
Circulating Tumor Cells as Biomarkers in Prostate Cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2011)
Molecular Characterization of Circulating Tumor Cells in Breast Cancer by a Liquid Bead Array Hybridization Assay
Athina Markou et al.
CLINICAL CHEMISTRY (2011)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: Initial results in early prostate cancer
John W. Davis et al.
JOURNAL OF UROLOGY (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy
RW Ross et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer
PW Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
